[Effect of bezafibrate on the carbohydrate metabolism of 17 diabetics with hyperlipidemia].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001629:Bezafibrate; D001835:Body Weight / Q000187:drug effects; D050260:Carbohydrate Metabolism; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D048909:Diabetes Complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D010919:Placebos
D000924:Anticholesteremic Agents; D010919:Placebos; D002995:Clofibric Acid; D002994:Clofibrate; D001629:Bezafibrate
Einfluss von Bezafibrat auf den Kohlenhydratstoffwechsel von 17 Diabetikern mit Hyperlipidämie.